Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 48.17%
March 31, 2026 47.19%
December 31, 2025 39.34%
September 30, 2025 41.07%
June 30, 2025 46.49%
March 31, 2025 46.61%
December 31, 2024 38.14%
September 30, 2024 39.32%
June 30, 2024 47.13%
March 31, 2024 46.22%
December 31, 2023 36.81%
September 30, 2023 41.29%
June 30, 2023 46.07%
March 31, 2023 50.04%
December 31, 2022 41.50%
September 30, 2022 41.52%
June 30, 2022 47.49%
Date Value
March 31, 2022 47.31%
December 31, 2021 41.51%
September 30, 2021 43.15%
June 30, 2021 46.83%
March 31, 2021 42.35%
December 31, 2020 33.32%
September 30, 2020 39.59%
June 30, 2020 41.17%
March 31, 2020 41.57%
December 31, 2019 41.36%
September 30, 2019 46.70%
June 30, 2019 48.14%
March 31, 2019 46.27%
December 31, 2018 42.12%
September 30, 2018 45.01%
June 30, 2018 37.56%
March 31, 2018 44.42%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 71.47%
Eli Lilly & Co. 85.78%
ANI Pharmaceuticals, Inc. 54.97%
EyePoint, Inc. -36.09%
Amylyx Pharmaceuticals, Inc. --

Gross Profit Margin (Quarterly) Related Metrics